Neurology

AxoSim Appoints Alif Saleh as Chief Executive Officer to Drive Market Adoption

Co-founder and previous CEO Lowry Curley becomes Chief Scientific Officer NEW ORLEANS, June 11, 2024 /PRNewswire/ -- AxoSim, a life…

1 week ago

Cala TAPS Therapy is Now Covered by Medicare for Essential Tremor Patients, And Company Appoints CEO and President

SAN MATEO, Calif., June 10, 2024 /PRNewswire/ -- Cala, the bioelectronic medicine leader, reached a major milestone: a positive Medicare…

1 week ago

Presentation at the Society of Nuclear Medicine & Molecular Imaging (SNMMI) 2024 Annual Meeting Highlights Ashvattha Product Candidates for Neuroinflammation Imaging and Treatment

Preclinical data highlights the therapeutic potential of Ashvattha’s novel CSF1R tyrosine kinase inhibitor (CSF1R dendranib) for multiple sclerosis (MS) based…

1 week ago

Klick Health Adds 18 Senior Leaders as 27-Year Double-Digit Growth Spurt Continues

Independent health agency continues to attract industry’s brightest minds; fortifies teams companywide as part of commitment to delivering industry-leading innovation,…

2 weeks ago

RapidAI Wins 2024 MedTech Breakthrough Award For “Best Care Coordination Platform”

Prestigious International Annual Awards Program Recognizes the Breakthrough Innovation of the RapidAI Clinical PlatformLOS ANGELES, June 06, 2024 (GLOBE NEWSWIRE)…

2 weeks ago

QuantalX Partners with the University of Illinois Chicago, Towards Successful US Commercialization

NEW YORK, June 5, 2024 /PRNewswire/ -- QuantalX Neuroscience Ltd, a pioneering medical technology company, is delighted to announce its…

2 weeks ago

Nanox Launches Artificial Intelligence Functionality in Second Opinions Platform

Nanox integrates FDA-cleared population health AI solutions into its Second Opinions service New AI capabilities available to patients who submit…

2 weeks ago

BioVie Announces Formation of Advisory Board for Bezisterim in Long COVID

Scientific Advisory Board to play pivotal role in guiding and accelerating bezisterim long COVID Phase 2b trial supported by an…

2 weeks ago